Postdoctoral Fellowship in Translational Cancer Nanotechnology Program

The MDACC – Rice NIH T32 Postdoctoral Program in Interdisciplinary Translational Cancer Nanotechnology is a NIH funded program that will provide young talented scientists an intensive two-year research experience and training in cancer nanotechnology that is based on a close collaboration between The University of Texas MD Anderson Cancer Center and Rice University. The program is geared toward scientists who aim to pursue integrated, translational research that is focused on advancing promising new nanotechnology-based diagnostics and therapeutics to improve cancer care. Therefore, the training will emphasize understanding of biological and clinical needs in development of new technologies and in modification of existing technologies in nanoscience. Each fellow will be co-mentored by two program faculty - one from MD Anderson Cancer Center and one from Rice University.

 

Program eligibility: per program requirement fellows “must be a citizen of the United States or have been lawfully admitted for permanent residence at the time of appointment.”

 

How to apply:  Application packages for this year are due by May 31, 2017 and may be found at:  www.mdanderson.org/nanotechT32